Alpha DNA Investment Management’s Lumen LUMN Stock Holding History

Alpha DNA Investment Management’s Portfolio LUMN Stock Details LUMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-895	Closed	-$11K	–	402
2021 Q1	$11K	Buy	+895	New	+$11.1K	0.01%	283

Other funds holding LUMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpha DNA Investment Management's LUMN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Lumen (LUMN) in Q2 2021, closing a stake of 895 shares — an estimated $11K sold.

Alpha DNA Investment Management first reported a position in LUMN in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 720 funds tracked by Wall St. Rank hold LUMN as of Q2 2021.

Alpha DNA Investment Management reported no remaining Lumen position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 895 Lumen shares in Q2 2021, an estimated $11K.
Alpha DNA Investment Management first reported a position in Lumen in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Lumen position peaked at $11K in Q1 2021.
720 funds tracked by Wall St. Rank held Lumen as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.